相关文章
RELATED ARTICLES详细介绍
长春西汀杂质标准品 提供图谱
随货提供:所有杂质对照品均随货提供HPLC,NMR,MS图谱及CoA证书。
杂质定制服务:我司有专业研发团队,可提供杂质定制服务,以大可能的满足您对杂质对照品的选购需求。
长春西汀杂质标准品 提供图谱
中文名称 | 英文名称 | CAS号 |
长春西汀标准品 | Vinpocetine | 71-9-5 |
长春西汀杂质A | Ethyl Vincaminate |
|
长春西汀杂质B | Apovincamine | 4880-92-6 |
长春西汀杂质C | methoxyvinpocetine |
|
长春西汀杂质D | dihydrovinpocetine | 57517-54-1 |
长春西汀杂质 | ethyl (41S,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a -octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine -12-carboxylate |
|
长春西汀杂质 | sodium (41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12, 13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5] naphthyridine-12-carboxylate | 59413-21-7 |
长春西汀杂质 | ethyl (41RS,12RS,13aRS)-13a-ethyl-2,3,41,5,6,12,13,13a- octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5] naphthyridine-12-carboxylate |
|
长春西汀杂质 | (41S,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid | 27773-65-5 |
长春西汀杂质 | (41S,13aS)-12-(ethoxycarbonyl)-13a-ethyl-2,3,41,5,6,13a-hexahydroindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine 4(1H)-oxide | 109741-24-4 |
长春西汀杂质 | methyl (41R,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 18374-18-0 |
长春西汀杂质 | methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-8-methoxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxyla | 57430-34-9 |
长春西汀杂质 | methyl (41S,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 6835-99-0 |
长春西汀杂质 | methyl (41R,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 58000-63-8 |
长春西汀杂质 | methyl (41S,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 83508-83-2 |
长春西汀杂质 | methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 83508-82-1 |
长春西汀杂质 | methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 38990-16-8 |
长春西汀杂质 | methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 38990-17-9 |
长春西汀杂质 | ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 77549-94-1 |
长春西汀杂质 | ethyl (41R,13aR)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 42971-12-0 |
长春西汀杂质 | ethyl (41S,13aR)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 85647-43-4 |
静脉滴注,开始剂量每天20mg,加入到适量的5%葡萄糖或0.9%氯化钠注射液中缓慢滴注,以后根据病情可增至每天30mg,或遵医嘱。
配制好的输液须在3小时内使用。静滴治疗后,推荐口服长春西汀片继续治疗。
肝,肾疾病患者不必进行剂量调整。
产品咨询
销售热线
微信公众号
移动端浏览